154 related articles for article (PubMed ID: 38078371)
1. Glutaminase inhibition as potential cancer therapeutics: current status and future applications.
Cyriac R; Lee K
J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2290911. PubMed ID: 38078371
[TBL] [Abstract][Full Text] [Related]
2. Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies.
Wang Z; Liu F; Fan N; Zhou C; Li D; Macvicar T; Dong Q; Bruns CJ; Zhao Y
Front Oncol; 2020; 10():589508. PubMed ID: 33194749
[TBL] [Abstract][Full Text] [Related]
3. Glutaminases regulate glutathione and oxidative stress in cancer.
Matés JM; Campos-Sandoval JA; de Los Santos-Jiménez J; Márquez J
Arch Toxicol; 2020 Aug; 94(8):2603-2623. PubMed ID: 32681190
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Targeting of Glutaminolysis as a Novel Strategy to Combat Cancer Stem Cells.
Kao TW; Chuang YC; Lee HL; Kuo CC; Shen YA
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499623
[TBL] [Abstract][Full Text] [Related]
5. Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition.
Lampa M; Arlt H; He T; Ospina B; Reeves J; Zhang B; Murtie J; Deng G; Barberis C; Hoffmann D; Cheng H; Pollard J; Winter C; Richon V; Garcia-Escheverria C; Adrian F; Wiederschain D; Srinivasan L
PLoS One; 2017; 12(9):e0185092. PubMed ID: 28950000
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic targeting of glutaminolysis as an essential strategy to combat cancer.
Matés JM; Di Paola FJ; Campos-Sandoval JA; Mazurek S; Márquez J
Semin Cell Dev Biol; 2020 Feb; 98():34-43. PubMed ID: 31100352
[TBL] [Abstract][Full Text] [Related]
7. Metabolic Reprogramming of Cancer by Chemicals that Target Glutaminase Isoenzymes.
Matés JM; Campos-Sandoval JA; de Los Santos-Jiménez J; Segura JA; Alonso FJ; Márquez J
Curr Med Chem; 2020; 27(32):5317-5339. PubMed ID: 31038055
[TBL] [Abstract][Full Text] [Related]
8. Targeting glutaminase-mediated glutamine dependence in papillary thyroid cancer.
Yu Y; Yu X; Fan C; Wang H; Wang R; Feng C; Guan H
J Mol Med (Berl); 2018 Aug; 96(8):777-790. PubMed ID: 29942976
[TBL] [Abstract][Full Text] [Related]
9. Metabolic fingerprinting reveals extensive consequences of GLS hyperactivity.
Rumping L; Pras-Raves ML; Gerrits J; Tang YF; Willemsen MA; Houwen RHJ; van Haaften G; van Hasselt PM; Verhoeven-Duif NM; Jans JJM
Biochim Biophys Acta Gen Subj; 2020 Mar; 1864(3):129484. PubMed ID: 31734463
[TBL] [Abstract][Full Text] [Related]
10. The role of glutaminase in cancer.
Masisi BK; El Ansari R; Alfarsi L; Rakha EA; Green AR; Craze ML
Histopathology; 2020 Mar; 76(4):498-508. PubMed ID: 31596504
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of glutaminolysis in combination with other therapies to improve cancer treatment.
Shen YA; Chen CL; Huang YH; Evans EE; Cheng CC; Chuang YJ; Zhang C; Le A
Curr Opin Chem Biol; 2021 Jun; 62():64-81. PubMed ID: 33721588
[TBL] [Abstract][Full Text] [Related]
12. A tale of two glutaminases: homologous enzymes with distinct roles in tumorigenesis.
Katt WP; Lukey MJ; Cerione RA
Future Med Chem; 2017 Jan; 9(2):223-243. PubMed ID: 28111979
[TBL] [Abstract][Full Text] [Related]
13. Brain Tumor Stem Cell Dependence on Glutaminase Reveals a Metabolic Vulnerability through the Amino Acid Deprivation Response Pathway.
Restall IJ; Cseh O; Richards LM; Pugh TJ; Luchman HA; Weiss S
Cancer Res; 2020 Dec; 80(24):5478-5490. PubMed ID: 33106333
[TBL] [Abstract][Full Text] [Related]
14. Critical role of glutamine metabolism in cardiomyocytes under oxidative stress.
Watanabe K; Nagao M; Toh R; Irino Y; Shinohara M; Iino T; Yoshikawa S; Tanaka H; Satomi-Kobayashi S; Ishida T; Hirata KI
Biochem Biophys Res Commun; 2021 Jan; 534():687-693. PubMed ID: 33213841
[TBL] [Abstract][Full Text] [Related]
15. Glutaminolysis is a metabolic route essential for survival and growth of prostate cancer cells and a target of 5α-dihydrotestosterone regulation.
Cardoso HJ; Figueira MI; Vaz CV; Carvalho TMA; Brás LA; Madureira PA; Oliveira PJ; Sardão VA; Socorro S
Cell Oncol (Dordr); 2021 Apr; 44(2):385-403. PubMed ID: 33464483
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of glutaminase 1-mediated glutaminolysis improves pathological cardiac remodeling.
Yoshikawa S; Nagao M; Toh R; Shinohara M; Iino T; Irino Y; Nishimori M; Tanaka H; Satomi-Kobayashi S; Ishida T; Hirata KI
Am J Physiol Heart Circ Physiol; 2022 May; 322(5):H749-H761. PubMed ID: 35275762
[TBL] [Abstract][Full Text] [Related]
17. LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in
Galan-Cobo A; Sitthideatphaiboon P; Qu X; Poteete A; Pisegna MA; Tong P; Chen PH; Boroughs LK; Rodriguez MLM; Zhang W; Parlati F; Wang J; Gandhi V; Skoulidis F; DeBerardinis RJ; Minna JD; Heymach JV
Cancer Res; 2019 Jul; 79(13):3251-3267. PubMed ID: 31040157
[TBL] [Abstract][Full Text] [Related]
18. The glutaminase inhibitor telaglenastat enhances the antitumor activity of signal transduction inhibitors everolimus and cabozantinib in models of renal cell carcinoma.
Emberley E; Pan A; Chen J; Dang R; Gross M; Huang T; Li W; MacKinnon A; Singh D; Sotirovska N; Steggerda SM; Wang T; Parlati F
PLoS One; 2021; 16(11):e0259241. PubMed ID: 34731180
[TBL] [Abstract][Full Text] [Related]
19. Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer.
Singleton DC; Dechaume AL; Murray PM; Katt WP; Baguley BC; Leung EY
BMC Cancer; 2020 May; 20(1):470. PubMed ID: 32450839
[TBL] [Abstract][Full Text] [Related]
20. Lactate promotes glutamine uptake and metabolism in oxidative cancer cells.
Pérez-Escuredo J; Dadhich RK; Dhup S; Cacace A; Van Hée VF; De Saedeleer CJ; Sboarina M; Rodriguez F; Fontenille MJ; Brisson L; Porporato PE; Sonveaux P
Cell Cycle; 2016; 15(1):72-83. PubMed ID: 26636483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
